J. B. Groce

438 total citations
30 papers, 310 citations indexed

About

J. B. Groce is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, J. B. Groce has authored 30 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 20 papers in Internal Medicine and 8 papers in Surgery. Recurrent topics in J. B. Groce's work include Venous Thromboembolism Diagnosis and Management (20 papers), Atrial Fibrillation Management and Outcomes (18 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (7 papers). J. B. Groce is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (20 papers), Atrial Fibrillation Management and Outcomes (18 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (7 papers). J. B. Groce collaborates with scholars based in United States, Canada and Spain. J. B. Groce's co-authors include Geno J. Merli, John L. Francis, William F. McCormick, Péter Gál, Allan L. Klein, Uri Elkayam, Pim Gal, Niranjan Seshadri, Sarah A. Spinler and Samuel Z. Goldhaber and has published in prestigious journals such as American Heart Journal, Thrombosis Research and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

J. B. Groce

29 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. B. Groce United States 8 177 171 117 37 26 30 310
Chiara Piovella Italy 8 138 0.8× 97 0.6× 57 0.5× 65 1.8× 5 0.2× 15 240
Gerben C. Mol Netherlands 6 251 1.4× 110 0.6× 134 1.1× 25 0.7× 6 0.2× 11 307
Diane Wirth United States 5 233 1.3× 253 1.5× 71 0.6× 55 1.5× 5 0.2× 12 397
S. Ziegler Austria 7 139 0.8× 107 0.6× 126 1.1× 25 0.7× 4 0.2× 10 320
A. Van Loo Belgium 6 56 0.3× 33 0.2× 125 1.1× 54 1.5× 5 0.2× 14 293
Stanislav Glezer United States 7 260 1.5× 230 1.3× 175 1.5× 29 0.8× 17 535
Lauren K. Stewart United States 9 200 1.1× 143 0.8× 42 0.4× 22 0.6× 1 0.0× 15 288
Yiu-Han Chan China 5 56 0.3× 105 0.6× 80 0.7× 33 0.9× 2 0.1× 12 333
Reinhard Germann Austria 9 21 0.1× 95 0.6× 79 0.7× 19 0.5× 12 0.5× 18 274
José María Suriñach Spain 8 70 0.4× 96 0.6× 55 0.5× 12 0.3× 15 169

Countries citing papers authored by J. B. Groce

Since Specialization
Citations

This map shows the geographic impact of J. B. Groce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. B. Groce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. B. Groce more than expected).

Fields of papers citing papers by J. B. Groce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. B. Groce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. B. Groce. The network helps show where J. B. Groce may publish in the future.

Co-authorship network of co-authors of J. B. Groce

This figure shows the co-authorship network connecting the top 25 collaborators of J. B. Groce. A scholar is included among the top collaborators of J. B. Groce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. B. Groce. J. B. Groce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aguilar, Carlos, Michelangelo Sartori, Armando D’Angelo, et al.. (2018). Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline. Blood Coagulation & Fibrinolysis. 29(6). 562–566. 5 indexed citations
2.
Groce, J. B., et al.. (2018). Pharmacy Student Monitoring of Direct Oral Anticoagulants. Journal of Pharmacy Practice. 31(5). 462–468. 6 indexed citations
3.
Kirk, Julienne K., et al.. (2017). Overview of a pharmacist anticoagulation certificate program. Currents in Pharmacy Teaching and Learning. 9(4). 707–712. 2 indexed citations
4.
Groce, J. B., et al.. (2017). A pilot process to identify and switch high-risk warfarin patients to direct oral anticoagulants. Journal of Hospital Administration. 6(5). 20–20. 3 indexed citations
5.
Groce, J. B.. (2008). Initial management of deep venous thrombosis in the outpatient setting. American Journal of Health-System Pharmacy. 65(9). 866–874. 5 indexed citations
7.
Deitelzweig, Steven, et al.. (2004). Anticoagulant Prophylaxis in Medical Patients: An Objective Assessment. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(8P2). 120S–126S. 2 indexed citations
8.
Francis, John L., et al.. (2004). Challenges in Variation and Responsiveness of Unfractionated Heparin. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(8P2). 108S–119S. 51 indexed citations
9.
Saw, Jacqueline, Dean J. Kereiakes, Kenneth W. Mahaffey, et al.. (2003). Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levels. Thrombosis Research. 112(5-6). 301–306. 10 indexed citations
10.
Groce, J. B.. (2003). “Bridging” Therapy with Low Molecular Weight Heparin in Pregnant Patients and Patients with Mechanical Prosthetic Heart Valves. Journal of Thrombosis and Thrombolysis. 16(1-2). 79–82. 3 indexed citations
11.
Groce, J. B.. (2001). Low-Molecular-Weight-Heparin differentiation: Issues and evolving evidence. 67(11). 52–61. 1 indexed citations
12.
Merli, Geno J., et al.. (2001). Applying Scientific Criteria to Therapeutic Interchange: A Balanced Analysis of Low-Molecular-Weight Heparins. Journal of Thrombosis and Thrombolysis. 11(3). 247–259. 25 indexed citations
13.
Groce, J. B.. (2001). Treatment of deep vein thrombosis using low-molecular-weight heparins.. PubMed. 7(17 Suppl). S510–5; discussion S515. 5 indexed citations
14.
Groce, J. B., et al.. (2001). DVT prophylaxis in medically ill patients: A new avenue of clinical management in the long-term care setting. 16. 7–17. 1 indexed citations
15.
Groce, J. B.. (1994). Anxiolytic and Sedative/Hypnotic Unnecessary Drug Use Evaluation. 8(4). 73–82. 2 indexed citations
16.
Gál, Péter, et al.. (1993). Rapid Determination of Maintenance Heparin Infusion Rates with the Use of Non-Steady-State Heparin Concentrations. Annals of Pharmacotherapy. 27(12). 1429–1433. 6 indexed citations
17.
Gál, Péter, et al.. (1992). Altered Heparin Pharmacodynamics in Patients with Pulmonary Embolism. Therapeutic Drug Monitoring. 14(5). 360–365. 3 indexed citations
18.
Groce, J. B., et al.. (1991). Rapid determination of maintenance heparin infusion rates with the use of non-steady state heparin concentrations. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 11. 280. 3 indexed citations
19.
Gal, Pim, et al.. (1990). Altered heparin pharmacodynamics in pulmonary embolism. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 10(3). 1 indexed citations
20.
Groce, J. B., et al.. (1987). Heparin dosage adjustment in patients with deep-vein thrombosis using heparin concentrations rather than activated partial thromboplastin time.. PubMed. 6(3). 216–22. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026